Immune responses to COVID-19 vaccination in people living with HIV

Zabrina Brumme, Ph.D.
Laboratory Director, BC Centre for Excellence in HIV/AIDS
Professor, Faculty of Health Sciences
Simon Fraser University
Scholar, Michael Smith Foundation for Health Research

Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025